India’s first COVID-19 mRNA vaccine has been given the go-ahead from the Director Controller General of India to move into the phase 2/3 clinical trials as it has been found safe.

Gennova Biopharmaceuticals Ltd., (an Emcure group of companies), a Pune-based biotechnology company that has been working on the nation’s first mRNA-based COVID-19 vaccine, The Indian Express (TIE) reported.
https://www.odishabytes.com/indias-first-mrna-vaccine-dcgi-approves...